How Neurogen Biomarking is Helping to Diagnose Alzheimer’s Earlier Than Ever Before

Elisabeth Thijssen, PhD, serves as the Chief Scientific Officer at Neurogen Biomarking, a company focused on early Alzheimer’s detection using blood biomarkers and digital cognitive assessments. Combining expertise in advanced neuroscience research and business strategy, Dr. Thijssen offers a distinctive viewpoint on one of medicine’s critical issues: identifying Alzheimer’s disease early, before it becomes irreversible.

After earning a PhD in neurodegenerative disease and publishing in leading journals such as Nature Medicine and The Lancet Neurology, Dr. Thijssen observed how slowly life-changing scientific breakthroughs reached patients. Her work in consulting and advising global life sciences organizations equipped her to bridge the gap between cutting-edge academic research and practical, scalable solutions.

As the CSO at Neurogen, Dr. Thijssen brings a perspective that’s deeply rooted in science. This isn’t just something that they have licensed or outsourced; they’ve helped shape the field of Alzheimer’s blood biomarkers from the inside out. The team’s core belief from the outset was that Alzheimer’s can be detected much earlier than people think, in an accurate way. Thanks to the company’s work, it is now possible to identify biological changes years before symptoms become severe. The work is based on validated biomarkers, peer-reviewed studies, and close collaboration with top neurologists worldwide. 

Neurogen aims to make early detection both scientifically rigorous and human-centered, emphasizing affordability and empowerment. The team works to transform discoveries from academic papers into accessible tools for the public, ensuring responsible and ethical delivery with expert guidance. 

As Dr. Thijssen concludes, “We envision a future where checking on your brain health is as routine and stigma-free as monitoring blood pressure, enabling people to take informed action long before symptoms interfere with daily life.”

To learn more about Neurogen Biomarking’s life-changing technologies, visit their website, https://neurogenbiomarking.com/.